Project Håtsa, an intensive outpatient treatment, case navigation, mental health services, and supportive services project that assists homeless families obtain permanent housing. - WestCare Pacific Islands, Inc. (WPI) is proposing the Project Håtsa, or Uplift, an intensive outpatient treatment, case navigation, mental health services, and supportive services project that uses the Housing First Model in assisting homeless and chronically homeless families in obtaining permanent housing and treatment for Substance Use Disorder (SUD) and/or Co-occurring Disorders (COD). WPI’s Goals and Objectives for Project Hatsa are as follows:
Goal 1: Increase access to culturally appropriate, client-centered substance use disorder treatment on Guam to reduce alcohol, illicit drug, and prescription drug misuse among homeless families. Objectives 1.1: Provide evidence-based intensive, integrated intensive outpatient treatment to 200 families (40 annually). 1.2 75% of families will complete the Uplift Program successfully. 1.3 75% of families will be substance free during the 30 days prior to discharge, and 70% will remain abstinent at 6-months post intake as evidenced by GPRA.
Goal 2: Enhance social and behavioral health functioning among homeless families living on Guam. Objectives 2.1: 80% of families who successfully complete treatment will obtain recovery housing at discharge and 70% will maintain their living arrangements at 6-months post intake as evidenced by the GPRA. 2.2: 80% of families who complete treatment will have improved social connectedness at discharge, and 70% will maintain these improvements at 6-months post intake as evidenced by GPRA. 2.3: 80% of families who complete treatment will enroll in an educational/vocational program, be actively seeking employment, or be employed at discharge, and 70% will continue to remain enrolled, complete their education/training, or remain employed 6-months post intake as evidenced by the GPRA. 2.4: 80% of families who complete treatment and who had mental health symptoms at admission will exhibit decreased symptoms at discharge, and 70% will maintain improved mental health functioning at 6- months post intake as evidenced by the GPRA and Modified Mini Screen.
